Siegmund Braun

Author PubWeight™ 70.40‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases. Nat Med 2010 4.32
2 Cytochrome 2C19*17 allelic variant, platelet aggregation, bleeding events, and stent thrombosis in clopidogrel-treated patients with coronary stent placement. Circulation 2010 3.68
3 Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med 2012 3.63
4 Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis. J Am Coll Cardiol 2009 3.15
5 Assessment of ADP-induced platelet aggregation with light transmission aggregometry and multiple electrode platelet aggregometry before and after clopidogrel treatment. Thromb Haemost 2008 2.46
6 Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel. Thromb Haemost 2009 2.09
7 Prognostic value of sensitive troponin T in patients with stable and unstable angina and undetectable conventional troponin. Am Heart J 2011 1.70
8 Prognostic value of uric acid in patients with acute coronary syndromes. Am J Cardiol 2012 1.67
9 Relation of fibrinogen level with cardiovascular events in patients with coronary artery disease. Am J Cardiol 2013 1.56
10 Inflammatory response after intervention assessed by serial C-reactive protein measurements correlates with restenosis in patients treated with coronary stenting. Am Heart J 2005 1.48
11 Platelet adhesion via glycoprotein IIb integrin is critical for atheroprogression and focal cerebral ischemia: an in vivo study in mice lacking glycoprotein IIb. Circulation 2005 1.25
12 Relation between plasma fibroblast growth factor-23, serum fetuin-A levels and coronary artery calcification evaluated by multislice computed tomography in patients with normal kidney function. Clin Endocrinol (Oxf) 2007 1.16
13 72-h kinetics of high-sensitive troponin T and inflammatory markers after marathon. Med Sci Sports Exerc 2011 1.04
14 Prognostic value of N-terminal pro-brain natriuretic peptide in patients with chronic stable angina. Circulation 2005 1.00
15 Predictive value of basal C-reactive protein levels for myocardial salvage in patients with acute myocardial infarction is dependent on the type of reperfusion treatment. Eur Heart J 2003 0.95
16 Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin. Anesth Analg 2008 0.94
17 Plasma levels of N-terminal pro-brain natriuretic peptide in patients with coronary artery disease and relation to clinical presentation, angiographic severity, and left ventricular ejection fraction. Am J Cardiol 2005 0.94
18 Prognostic value of plasma myeloperoxidase concentration in patients with stable coronary artery disease. Am Heart J 2007 0.93
19 Association between C-reactive protein levels and subsequent cardiac events among patients with stable angina treated with coronary artery stenting. Am J Med 2003 0.92
20 Clopidogrel response status assessed with Multiplate point-of-care analysis and the incidence and timing of stent thrombosis over six months following coronary stenting. Thromb Haemost 2009 0.91
21 Impact of bivalirudin or unfractionated heparin on platelet aggregation in patients pretreated with 600 mg clopidogrel undergoing elective percutaneous coronary intervention. Eur Heart J 2008 0.90
22 Uric acid and prognosis in angiography-proven coronary artery disease. Eur J Clin Invest 2012 0.90
23 High-sensitivity troponin T level and angiographic severity of coronary artery disease. Am J Cardiol 2011 0.89
24 ABO locus O1 allele and risk of myocardial infarction. Blood Coagul Fibrinolysis 2004 0.89
25 Choice of contrast medium in patients with impaired renal function undergoing percutaneous coronary intervention. Circ Cardiovasc Interv 2009 0.88
26 A double-blind, randomized study on prevention and existence of a rebound phenomenon of platelets after cessation of clopidogrel treatment. J Am Coll Cardiol 2010 0.88
27 Impaired cardiac autonomic nervous activity predicts sudden cardiac death in patients with operated and unoperated congenital cardiac disease. J Thorac Cardiovasc Surg 2006 0.87
28 Methylenetetrahydrofolate reductase gene C677T and A1298C polymorphisms, plasma homocysteine, folate, and vitamin B12 levels and the extent of coronary artery disease. Am J Cardiol 2004 0.87
29 Cardiopulmonary bypass with physiological flow and pressure curves: pulse is unnecessary! Eur J Cardiothorac Surg 2009 0.85
30 Peak cardiac troponin-T level, scintigraphic myocardial infarct size and one-year prognosis in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol 2010 0.85
31 Association between inflammatory biomarkers and platelet aggregation in patients under chronic clopidogrel treatment. Thromb Haemost 2010 0.83
32 Homocysteine status and polymorphisms of methylenetetrahydrofolate reductase are not associated with restenosis after stenting in coronary arteries. Arterioscler Thromb Vasc Biol 2003 0.83
33 Circulating homocysteine levels in patients with type 2 diabetes mellitus. Nutr Metab Cardiovasc Dis 2006 0.83
34 Impact of therapy with statins, beta-blockers and angiotensin-converting enzyme inhibitors on plasma myeloperoxidase in patients with coronary artery disease. Clin Res Cardiol 2010 0.82
35 Coronary revascularization in patients with renal insufficiency: restenosis rate and cardiovascular outcomes. Am J Kidney Dis 2004 0.82
36 Systemic inflammatory changes after pulmonary vein radiofrequency ablation do not alter stem cell mobilization. Europace 2008 0.82
37 Tumor necrosis factor-α -863 C/A promoter polymorphism affects the inflammatory response after cardiac surgery. Eur J Cardiothorac Surg 2011 0.82
38 Effects of aspirin and clopidogrel versus oral anticoagulation on platelet function and on coagulation in patients with nonvalvular atrial fibrillation (CLAFIB). Pathophysiol Haemost Thromb 2002 0.82
39 No association of ABCB1 C3435T genotype with clopidogrel response or risk of stent thrombosis in patients undergoing coronary stenting. Circ Cardiovasc Interv 2012 0.82
40 Accuracy of N-terminal pro-brain natriuretic peptide to predict mortality in various subsets of patients with coronary artery disease. Am J Cardiol 2007 0.81
41 A prospective cohort study of prognostic power of N-terminal probrain natriuretic peptide in patients with non-ST segment elevation acute coronary syndromes. Clin Res Cardiol 2006 0.81
42 Clopidogrel therapy in patients undergoing coronary stenting: value of a high-loading-dose regimen. Catheter Cardiovasc Interv 2002 0.81
43 N-terminal probrain natriuretic peptide and C-reactive protein in stable coronary heart disease. Am J Med 2006 0.80
44 Enhanced thrombin generation after cardiopulmonary bypass surgery. Anesth Analg 2010 0.80
45 Stability of the high on-treatment platelet reactivity phenotype over time in clopidogrel-treated patients. Thromb Haemost 2010 0.80
46 Nonalcoholic beer reduces inflammation and incidence of respiratory tract illness. Med Sci Sports Exerc 2012 0.79
47 Assessment of platelet response to clopidogrel with multiple electrode aggregometry, the VerifyNow P2Y12 analyzer and platelet Vasodilator-Stimulated Phosphoprotein flow cytometry. Blood Coagul Fibrinolysis 2010 0.79
48 Coronary atherosclerosis burden, but not transient troponin elevation, predicts long-term outcome in recreational marathon runners. Basic Res Cardiol 2013 0.79
49 Total leucocyte count, but not C-reactive protein, predicts 1-year mortality in patients with acute coronary syndromes treated with percutaneous coronary intervention. Clin Sci (Lond) 2009 0.79
50 Association of uric acid with mortality in patients with stable coronary artery disease. Metabolism 2012 0.78
51 Prognostic value of uric acid in patients with Type 2 diabetes mellitus and coronary artery disease. Clin Sci (Lond) 2013 0.78
52 Predictors of antiplatelet response to prasugrel during maintenance treatment. Platelets 2014 0.78
53 A prospective cohort study of predictive value of homocysteine in patients with type 2 diabetes and coronary artery disease. Clin Chim Acta 2006 0.78
54 Oral anticoagulation with coumarin derivatives and antiplatelet effects of clopidogrel. Eur Heart J 2010 0.78
55 Accuracy of N-terminal probrain natriuretic peptide to predict mortality or detect acute ischemia in patients with coronary artery disease. Cardiology 2007 0.78
56 The perioperative course of factor XIII and associated chest tube drainage in newborn and infants undergoing cardiac surgery. Paediatr Anaesth 2013 0.77
57 N-terminal pro-brain natriuretic peptide on admission in patients with acute myocardial infarction and correlation with scintigraphic infarct size, efficacy of reperfusion, and prognosis. Am J Cardiol 2006 0.77
58 High frequency of CYP2C19*2 carriers in PCI-treated patients switched over from clopidogrel to prasugrel based on platelet function monitoring. Platelets 2012 0.77
59 C-reactive protein and prognosis in women and men with coronary artery disease after percutaneous coronary intervention. Cardiovasc Revasc Med 2013 0.77
60 Sensitive troponin and N-terminal probrain natriuretic peptide in stable angina. Eur J Clin Invest 2011 0.77
61 Statistical design and analysis of label-free LC-MS proteomic experiments: a case study of coronary artery disease. Methods Mol Biol 2011 0.76
62 Antiplatelet efficacy of prasugrel in patients with high on-clopidogrel treatment platelet reactivity and a history of coronary stenting. Thromb Haemost 2013 0.76
63 Assessment of platelet function in whole blood by multiple electrode aggregometry: transport of samples using a pneumatic tube system. Am J Clin Pathol 2009 0.75
64 Reply: Aspirin Treatment and Outcomes After Percutaneous Coronary Intervention: Results of the ISAR-ASPI Registry. J Am Coll Cardiol 2015 0.75
65 Comparative prognostic value of C-reactive protein & fibrinogen in patients with coronary artery disease. Indian J Med Res 2014 0.75
66 Iron status and clinical outcome in patients with coronary artery disease after coronary stenting. Nutr Metab Cardiovasc Dis 2005 0.75
67 Epidemiology, risk factors and clinical role of TT virus infection in polytransfused patients after cardiac surgery in childhood: impact of HCV co infection. J Clin Virol 2006 0.75
68 Prevalence and clinical role of GBV-C infection after cardiac surgery in childhood: a study on 414 patients. J Infect 2005 0.75
69 Prolonged Elevated Cardiac Troponin After Marathon Running Is A Sign For Myocardial Damage: 2307 June 2, 5: 00 PM - 5: 15 PM. Med Sci Sports Exerc 2016 0.75
70 Oxidized low density lipoproteins, statin therapy and severity of coronary artery disease. Clin Chim Acta 2005 0.75
71 The influence of antithrombin substitution on heparin sensitivity and activation of hemostasis during coronary artery bypass graft surgery: a dose-finding study. Anesth Analg 2013 0.75
72 No difference in postoperative cardiac troponin T between a sevoflurane- or midazolam-supplemented opioid anesthetic in patients undergoing on-pump coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 2006 0.75
73 Rutoside and Hydrolytic Enzymes Do Not Attenuate Marathon-induced Inflammation. Med Sci Sports Exerc 2016 0.75
74 Comparison of prognostic value of high-sensitivity and conventional troponin T in patients with non-ST-segment elevation acute coronary syndromes. Clin Chim Acta 2011 0.75
75 Factor V Leiden does not affect bleeding in aprotinin recipients after cardiopulmonary bypass. Anesthesiology 2007 0.75
76 Association of midregional proadrenomedullin with coronary artery stenoses, soft atherosclerotic plaques and coronary artery calcium. Heart Vessels 2011 0.75